The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...
The combined clinicopathological factors and gene-expression profile (CP-GEP) test can identify which patients with primary ...
A woman who dismissed blood in her stool as hemorrhoids was diagnosed with stage three colon cancer. Meagan Meadows, 24, ...
Introduction From 2012 to 2017, the Cervical Cancer Prevention in El Salvador (CAPE) piloted and scaled up a human ...
MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...
Everyday Health on MSN
What Is a Prostate Biopsy?
A prostate biopsy involves removing prostate tissue to test for cancer. Learn about types, procedure, risks, and follow-up ...
Liquid biopsies analyze materials like circulating tumor DNA (ctDNA) in the blood to provide a non-invasive look at a cancer’s genetic profile. They are highly effective for tracking tumor evolution, ...
SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI ...
Kihealth, a company specializing in molecular diagnostics, announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85th Scientific Session held in Chicago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback